Clinical and economic characteristics of patients with fibromyalgia syndrome

Clinical Journal of Pain

Volumn 26, Issue 4, 2010, Pages 284-290

  Lachaine, Jean ^a   Beauchemin, Catherine ^a   Landry, Pierre Alexandre ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b PFIZER INC   (United States)

Author keywords

Administrative databases; Cost analysis; Drug utilization; Fibromyalgia

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIMIGRAINE AGENT; BENZODIAZEPINE DERIVATIVE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; HYPNOTIC SEDATIVE AGENT; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANADA; CHRONIC DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; COST OF ILLNESS; ECONOMIC ASPECT; FEMALE; FIBROMYALGIA; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL ANALYSIS;

EID: 77951457223     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e3181cf599f     Document Type: Article

References (24)

1. National Institute of Arthritis and Musculoskeletal and Skin Disease. Questions and Answers About Fibromyalgia. Internet Source 2008Available from: URL: http://www.niams.nih.gov/
2. Chakrabarty S, Zoorob R. Fibromyalgia. Am Fam Physician. 2007;76:247-254.
3. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004;292:2388-2395.
4. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Internet Source 2008 Available from: URL: http://www. rheumatology.org/publications/classification/fibromyalgia/fibro.asp
5. Dadabhoy D, Clauw DJ. Therapy insight: fibromyalgia\a different type of pain needing a different type of treatment. Nat Clin Pract Rheumatol. 2006;2:364-372.
6. Julien N, Goffaux P, Arsenault P, et al. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain. 2005;114:295-302.
7. Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol. 2003;17:685-701.
8. Croft P, Rigby AS, Boswell R, et al. The prevalence of chronic widespread pain in the general population. J Rheumatol. 1993; 20:710-713.
9. Wolfe F, Ross K, Anderson J, et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19-28.
10. Weir PT, Harlan GA, Nkoy FL, et al. The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on international classification of diseases, 9th revision codes. J Clin Rheumatol. 2006;12:124-128.
11. McNally JD, Matheson DA, Bakowsky VS. The epidemiology of self-reported fibromyalgia in Canada. Chronic Dis Can. 2006;27:9-16.
12. White KP, Speechley M, Harth M, et al. The London fibromyalgia epidemiology study: the prevalence of fibro-myalgia syndrome in London, Ontario. J Rheumatol. 1999;26: 1570-1576. (Pubitemid 29317882)
13. Berger A, Dukes E, Martin S, et al. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract. 2007;61:1498-1508.
14. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl. 2005;75:6-21
15. Journal of Musculoskeletal Pain, Fibromyalgia Syndrome: Canadian Clinical Working Case Definition, Diagnostic and Treatment Protocols\A Consensus Document, Internet source, 2004, Available from URL: http://www.fm-cfs.ca/FM- Guidelines-Journal.pdf
16. Bernatsky S, Dobkin PL, De CM, et al. Co-morbidity and physician use in fibromyalgia. Swiss Med Wkly. 2005;135: 76-81.
17. Penrod JR, Bernatsky S, Adam V, et al. Health services costs and their determinants in women with fibromyalgia. J Rheumatol. 2004;31:1391-1398.
18. Hughes G, Martinez C, Myon E, et al. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum. 2006;54:177-183.
19. Robinson RL, Birnbaum HG, Morley MA, et al. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol. 2003;30:1318-1325.
20. White LA, Birnbaum HG, Kaltenboeck A, et al. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med. 2008;50:13-24.
21. Wolfe F, Anderson J, Harkness D, et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum. 1997;40:1560-1570.
22. Von KM, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45: 197-203.
23. Eisenberg MJ, Filion KB, Azoulay A, et al. Outcomes and cost of coronary artery bypass graft surgery in the United States and Canada. Arch Intern Med. 2005;165: 1506-1513.
24. Quam L, Ellis LB, Venus P, et al. Using claims data for epidemiologic research. The concordance of claims-based criteria with the medical record and patient survey for identifying a hypertensive population. Med Care. 1993;31:498-507.